X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (96) 96
Book Review (93) 93
Book / eBook (17) 17
Book Chapter (8) 8
Publication (8) 8
Web Resource (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
book reviews (45) 45
history (36) 36
books (34) 34
index medicus (21) 21
humans (20) 20
religion (16) 16
male (15) 15
nonfiction (13) 13
area studies (11) 11
female (11) 11
humanities, multidisciplinary (11) 11
middle aged (10) 10
aged (8) 8
electronic books (8) 8
germany (7) 7
stem cells (7) 7
surgery (7) 7
19th century (6) 6
cardiac & cardiovascular systems (6) 6
politics (6) 6
protestantism (6) 6
abridged index medicus (5) 5
analysis (5) 5
biomedicine (5) 5
cardiovascular diseases (5) 5
catholicism (5) 5
cell biology (5) 5
culture (5) 5
disease (5) 5
physicians (5) 5
regeneration (5) 5
regenerative medicine (5) 5
20th century (4) 4
adult (4) 4
authors, german (4) 4
biomaterials (4) 4
biomedicine general (4) 4
cardiovascular disease (4) 4
cells (4) 4
dermatology (4) 4
double-blind method (4) 4
elite (4) 4
german (4) 4
heart attacks (4) 4
in-vivo (4) 4
life sciences (4) 4
medical (4) 4
medical profession (4) 4
medicine (4) 4
medicine, general & internal (4) 4
molecular medicine (4) 4
mortality (4) 4
music (4) 4
philosophy (4) 4
progenitor cells (4) 4
risk factors (4) 4
social aspects (4) 4
treatment outcome (4) 4
animals (3) 3
art (3) 3
aufsatzsammlung (3) 3
biography (3) 3
book review (3) 3
book reviews and notes (3) 3
cardiovascular (3) 3
care and treatment (3) 3
cerebral infarction (3) 3
clinical sciences (3) 3
clinical trials (3) 3
colony-forming units (3) 3
cultural identity (3) 3
drug therapy (3) 3
essays (3) 3
europe (3) 3
european history (3) 3
family & general practice (3) 3
further section (3) 3
germany intellectual life (3) 3
germany social life and customs (3) 3
health & fitness (3) 3
human biology (3) 3
infectious diseases (3) 3
intellectual life (3) 3
internal medicine (3) 3
kuczynski, rita (3) 3
management (3) 3
medical / family & general practice (3) 3
medical sciences (3) 3
medicine & public health (3) 3
metaanalysis (3) 3
mitral valve - surgery (3) 3
mitral valve insufficiency - surgery (3) 3
molecular biology (3) 3
mother cells (3) 3
myocardial infarction (3) 3
myocardial-infarction (3) 3
pathology (3) 3
patients (3) 3
proteins (3) 3
quality of life (3) 3
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (4) 4
Online Resources - Online (2) 2
UTL at Downsview - May be requested (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
Robarts - Library use only (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article